{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T15:16:57Z","timestamp":1770823017532,"version":"3.50.1"},"reference-count":42,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2006,7,17]],"date-time":"2006-07-17T00:00:00Z","timestamp":1153094400000},"content-version":"vor","delay-in-days":5656,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intl Journal of Cancer"],"published-print":{"date-parts":[[1991,1,21]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>We examined multiple samples of 65 primary breast carcinomas larger than I cm in diameter for thymidine labelling index (TLI), DNA index (DNAI, a measure of cellular DNA content by flow cytometry), and estrogen (ER) and progesterone (PgR) receptors by radioligand\u2010binding. One or more axillary metastases were also assayed in 11 patients. Two to 15 samples were successfully assayed for TLI from 59 tumors, 2\u201031 samples for DNAI from 61 tumors, and 2\u201015 samples from 55 tumors for ER and PgR. Criteria for heterogeneity were excess inter\u2010sample variance in comparison with intra\u2010sample variance at the <jats:italic>p<\/jats:italic> &lt; 0.05 level for TLI and DNAI, and variation of clinically significant magnitude in assay results for ER and PgR. Sixty\u2010one percent of tumors were heterogeneous for TLI, 26% for DNAI, 24% for ER and 40% for PgR. High TLI disposed toward heterogeneity for TLI itself (<jats:italic>p<\/jats:italic> = 0.06), for ER (<jats:italic>p<\/jats:italic> = 0.04), and for PgR (<jats:italic>p<\/jats:italic> = 0.007). Young age favored heterogeneity for TLI (<jats:italic>p<\/jats:italic> = 0.12), ER (<jats:italic>p<\/jats:italic> = 0.002), and PgR (<jats:italic>p<\/jats:italic> = 0.04). Heterogeneity for DNAI was not related to age and TLI status but was more common in larger tumors (<jats:italic>p<\/jats:italic> = 0.08). After consideration of relationships between TLI, age, size, ER and PgR, TLI rather than age appears to be the more important determinant of heterogeneity for receptors. High TLI could lead to heterogeneity through increased numbers of cell divisions that favor emergence of variant stemlines, or by causing local vascular and humoral disparities through rapid growth. Regional heterogeneity can explain erroneous prognostic predictions in approximately 10% to 20% of breast carcinoma patients. We recommend multiple sampling of large breast carcinomas and analysis of axillary metastases for study of tumor markers.<\/jats:p>","DOI":"10.1002\/ijc.2910470209","type":"journal-article","created":{"date-parts":[[2007,2,19]],"date-time":"2007-02-19T22:06:47Z","timestamp":1171922807000},"page":"213-220","source":"Crossref","is-referenced-by-count":49,"title":["Regional heterogeneity in breast carcinoma: Thymidine labelling index, steroid hormone receptors, dna ploidy"],"prefix":"10.1002","volume":"47","author":[{"given":"John S.","family":"Meyer","sequence":"first","affiliation":[]},{"given":"James L.","family":"Wittliff","sequence":"additional","affiliation":[]}],"member":"311","published-online":{"date-parts":[[2006,7,17]]},"reference":[{"key":"e_1_2_1_2_1","doi-asserted-by":"publisher","DOI":"10.1002\/cyto.990100312"},{"key":"e_1_2_1_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/0014-2964(80)90160-7"},{"key":"e_1_2_1_4_1","first-page":"9","article-title":"Private and public autocrine loops in neoplastic cells","volume":"1","author":"Browder T. M.","year":"1989","journal-title":"Cancer Cells"},{"key":"e_1_2_1_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/0277-5379(87)90415-9"},{"key":"e_1_2_1_6_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198903093201003"},{"key":"e_1_2_1_7_1","first-page":"26","volume":"5","author":"Daver A.","year":"1986","journal-title":"Proc. ASCO"},{"key":"e_1_2_1_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/0277-5379(84)90084-1"},{"key":"e_1_2_1_9_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM197911013011826"},{"key":"e_1_2_1_10_1","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19880801)62:3<521::AID-CNCR2820620314>3.0.CO;2-F"},{"key":"e_1_2_1_11_1","doi-asserted-by":"publisher","DOI":"10.1002\/jcla.1860030302"},{"key":"e_1_2_1_12_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF00402728"},{"key":"e_1_2_1_13_1","first-page":"4729","article-title":"Association of DNA index and S\u2010phase fraction with prognosis of nodes\u2010positive early breast cancer","volume":"47","author":"Hedley D. W.","year":"1987","journal-title":"Cancer Res."},{"key":"e_1_2_1_14_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF01806381"},{"key":"e_1_2_1_15_1","first-page":"296","article-title":"Endocrine therapy for advanced carcinoma of the breast: effect of tumor heterogeneity and site of biopsy on the predictive value of progesterone receptor estimations","volume":"47","author":"Howell A.","year":"1987","journal-title":"Cancer Res."},{"key":"e_1_2_1_16_1","first-page":"233","article-title":"Recognition of estrogen receptor isoforms from human breast cancer by immobilized monoclonal antibodies","volume":"9","author":"Hyder S. M.","year":"1988","journal-title":"Tumor Diagnostik Therapie"},{"key":"e_1_2_1_17_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF01806790"},{"issue":"8","key":"e_1_2_1_18_1","first-page":"4244s","article-title":"Use of a monoclonal anti\u2010estrogen receptor antibody in the immunohistochemical evaluation of human tumors","volume":"46","author":"McCarty K. S.","year":"1986","journal-title":"Cancer Res."},{"key":"e_1_2_1_19_1","doi-asserted-by":"publisher","DOI":"10.3109\/10520297709116774"},{"key":"e_1_2_1_20_1","doi-asserted-by":"publisher","DOI":"10.1093\/ajcp\/89.5.586"},{"key":"e_1_2_1_21_1","first-page":"160","article-title":"Reliability and stability of the thymidine labeling index of breast carcinoma","volume":"54","author":"Meyer J. S.","year":"1986","journal-title":"Lab. Invest."},{"key":"e_1_2_1_22_1","first-page":"41","article-title":"Breast carcinoma cell kinetics, morphology, stage, and host characteristics","volume":"54","author":"Meyer J. S.","year":"1986","journal-title":"Lab. Invest."},{"key":"e_1_2_1_23_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF01805940"},{"key":"e_1_2_1_24_1","doi-asserted-by":"publisher","DOI":"10.1093\/ajcp\/70.4.655"},{"key":"e_1_2_1_25_1","first-page":"181","volume-title":"Introduction to the theory of statistics","author":"Mood A. M.","year":"1963"},{"key":"e_1_2_1_26_1","first-page":"4904","article-title":"Growth\u2010stimulatory effect of androgen\u2010induced autocrine growth factor(s) secreted from Shionogi carcinoma cells on androgen\u2010unresponsive cancer cells in a paracrine mechanism","volume":"48","author":"Nonomura N.","year":"1988","journal-title":"Cancer Res."},{"key":"e_1_2_1_27_1","doi-asserted-by":"publisher","DOI":"10.1210\/endo-116-4-1473"},{"key":"e_1_2_1_28_1","doi-asserted-by":"publisher","DOI":"10.1002\/jso.2930290111"},{"key":"e_1_2_1_29_1","doi-asserted-by":"publisher","DOI":"10.1002\/cyto.990030109"},{"key":"e_1_2_1_30_1","first-page":"30","article-title":"Direct evidence of heterogeneity in the stem\u2010cell population of a breast\u2010cancer metastasis","volume":"25","author":"Ruta C.","year":"1984","journal-title":"Proc. Amer. Assoc. Cancer Res."},{"key":"e_1_2_1_31_1","first-page":"1398","article-title":"Epidermal\u2010growth\u2010factor receptor status as predictor of early recurrence of and death from breast cancer","author":"Sainsbury J. R.","year":"1987","journal-title":"Lancet"},{"key":"e_1_2_1_32_1","first-page":"1001","article-title":"Proliferative rates of cloned malignant mammary epithelial cells as a measure of clonal heterogeneity in human breast carcinomas","volume":"77","author":"Schmidt U. R.","year":"1986","journal-title":"J. nat. Cancer Inst."},{"key":"e_1_2_1_33_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF01806246"},{"key":"e_1_2_1_34_1","first-page":"331","article-title":"The errors of thymidine labeling in breast cancer","volume":"9","author":"Smallwood J. A.","year":"1983","journal-title":"Clin. Oncol."},{"key":"e_1_2_1_35_1","doi-asserted-by":"publisher","DOI":"10.1002\/jso.2930300307"},{"key":"e_1_2_1_36_1","doi-asserted-by":"publisher","DOI":"10.1016\/0014-2964(67)90022-9"},{"key":"e_1_2_1_37_1","doi-asserted-by":"publisher","DOI":"10.1002\/cyto.990060413"},{"key":"e_1_2_1_38_1","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.2910440104"},{"key":"e_1_2_1_39_1","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19851015)56:8<2019::AID-CNCR2820560822>3.0.CO;2-4"},{"key":"e_1_2_1_40_1","first-page":"370","article-title":"Multiparametric deoxyribonucleic acid cell\u2010cycle analysis of breast carcinomas by flow cytometry","volume":"62","author":"Visscher D. W.","year":"1990","journal-title":"Lab. Invest."},{"key":"e_1_2_1_41_1","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19840201)53:3 <630::AID-CNCR2820531308>3.0.CO;2-3"},{"key":"e_1_2_1_42_1","first-page":"767","volume-title":"Methods in clinical chemistry","author":"Wittliff J. L.","year":"1987"},{"key":"e_1_2_1_43_1","first-page":"303","volume-title":"Cancer of the breast","author":"Wittliff J. L.","year":"1988"}],"container-title":["International Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fijc.2910470209","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/ijc.2910470209","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,22]],"date-time":"2023-10-22T21:21:25Z","timestamp":1698009685000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/ijc.2910470209"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1991,1,21]]},"references-count":42,"journal-issue":{"issue":"2","published-print":{"date-parts":[[1991,1,21]]}},"alternative-id":["10.1002\/ijc.2910470209"],"URL":"https:\/\/doi.org\/10.1002\/ijc.2910470209","archive":["Portico"],"relation":{},"ISSN":["0020-7136","1097-0215"],"issn-type":[{"value":"0020-7136","type":"print"},{"value":"1097-0215","type":"electronic"}],"subject":[],"published":{"date-parts":[[1991,1,21]]}}}